Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL946177 | 1.00 | CA2 (0.34) | CA2GABRA1GABRB2 | |
| SCHEMBL29449704 | 0.90 | ALDH1A1 (0.33) | CA2 | |
| SCHEMBL23631853 | 0.82 | HSP90AA1 (0.37) | — | |
| SCHEMBL20994039 | 0.79 | GRIN2D (0.33) | CA2 | |
| SCHEMBL23631851 | 0.79 | — | — | |
| SCHEMBL6820489 | 0.79 | PTPRC (0.46) | — | |
| SCHEMBL18546122 | 0.74 | — | — | |
| SCHEMBL15322615 | 0.72 | ALOX15 (0.34) | — | |
| SCHEMBL30945595 | 0.71 | CHKA (0.32) | CA2 | |
| SCHEMBL29894137 | 0.71 | CHKA (0.32) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2148836-B1 | METHOD FOR THE PREPARATION OF REACTIVE [18]F FLUORIDE | TRASIS S A (BE) | 2017-10-25 | — | — | EP | claimed |
| US-8641903-B2 | Method for the preparation of reactive [18] F fluoride | TRASIS S.A. (BE) | 2014-02-04 | — | — | US | claimed |
| US-8366934-B2 | Method for the elution of 18F fluoride trapped on an anion-exchange phase in a form suitable for efficient radiolabeling without any evaporation step | TRASIS S.A. (BE) | 2013-02-05 | — | — | US | claimed |
| US-20110006011-A1 | METHOD FOR THE ELUTION OF 18F FLUORIDE TRAPPED ON AN ANION-EXCHANGE PHASE IN A FORM SUITABLE FOR EFFICIENT RADIOLABELING WITHOUT ANY EVAPORATION STEP | TRASIS S.A. (BE) | 2011-01-13 | — | — | US | claimed |
| US-20100243972-A1 | METHOD FOR THE PREPARATION OF REACTIVE [18] F FLUORIDE | TRASIS S.A. (BE) | 2010-09-30 | — | — | US | claimed |
| EP-2017359-A2 | Method for the elution of 18F fluoride trapped on an anion-exchange resin in a form suitable for efficient radiolabeling without any evaporation step | Trasis S.A. (BE) | 2009-01-21 | — | — | EP | claimed |
| EP-1990310-A1 | Method for the preparation of reactive 18F fluoride, and for the labeling of radiotracers, using a modified non-ionic solid support and without any evaporation step | Trasis S.A. (BE) | 2008-11-12 | — | — | EP | claimed |
| EP-1125951-B1 | Polymerization catalyst | INTEVEP SA (VE) | 2003-09-24 | — | — | EP | claimed |
| EP-1125951-A1 | Polymerization catalyst | Intevep SA (VE) | 2001-08-22 | — | — | EP | claimed |
| EP-0810235-A2 | Polymerization catalyst | Intevep SA (VE) | 1997-12-03 | — | — | EP | claimed |
| WO-2026102309-A1 | SELECTIVE RADIOTRACERS AND METHODS OF USE | LUTROO IMAGING, LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| US-12623942-B2 | Method for extracting salts and temperature- regenerated extracting composition | ADIONICS (FR) | 2026-05-12 | — | — | US | disclosed |
| US-20250352676-A1 | N-Cyclopropyl-1-(4-(4-(Fluoro-18f)Phenyl)Pyrimidin-5-Yl)-N-Methylpiperidine- 4-Carboxamide and Uses in PET Imaging | UNIV EMORY (US) | 2025-11-20 | — | — | US | disclosed |
| WO-2024035925-A2 | N-CYCLOPROPYL-1-(4-(4-(FLUORO-18F)PHENYL)PYRIMIDIN-5-YL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE AND USES IN PET IMAGING | EMORY UNIVERSITY (US) | 2024-02-15 | — | — | WO | disclosed |
| US-20230382775-A1 | METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION | ADIONICS (FR) | 2023-11-30 | — | — | US | disclosed |
| EP-0810235-A2 | Polymerization catalyst | Intevep SA (VE) | 1997-12-03 | — | — | EP | disclosed |
| EP-0747210-A2 | A laminated glass and an interlayer film for the same | SEKISUI CHEMICAL CO., LTD. (JP) | 1996-12-11 | — | — | EP | disclosed |
| CN-1126206-A | Process for the production of dianthraquinone-N,N'-dihydroazine | MITSUI TOATSU CHEMICALS (JP) | 1996-07-10 | — | — | CN | disclosed |
| US-5415909-A | Ethylene-vinyl acetate, silane coupler | SEKISUI CHEMICAL CO., LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| EP-0602644-A1 | An interlayer film and laminated glass using the same | SEKISUI CHEMICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12623942-B2 | Method for extracting salts and temperature- regenerated extracting composition | POLQ, NONO, AQP3 | CA2 203/4885GABRA1 3587/4885GABRB2 2821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.